Acquisition by Multani Pratik S of 145000 shares of Oric PharmaceuticalsI subject to Rule 16b-3

ORIC Stock  USD 8.77  0.05  0.57%   
About 56% of Oric PharmaceuticalsI's investor base is looking to short. The analysis of the overall investor sentiment regarding Oric PharmaceuticalsInc suggests that many traders are alarmed. Oric PharmaceuticalsI's investor sentiment overview provides quick insight into current market opportunities from investing in Oric PharmaceuticalsInc. The current market sentiment, together with Oric PharmaceuticalsI's historical and current headlines, can help investors time the market. In addition, many technical investors use Oric PharmaceuticalsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Oric PharmaceuticalsI stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Oric daily returns and investor perception about the current price of Oric PharmaceuticalsInc as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Oric Pharmaceuticals Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Oric PharmaceuticalsI insider trading alert for grant of stock option right to buy by Multani Pratik S, Chief Medical Officer, on 2nd of February 2023. This event was filed by Oric Pharmaceuticals Inc with SEC on 2023-02-02. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Oric PharmaceuticalsI's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Oric PharmaceuticalsI's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Oric PharmaceuticalsI Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Oric PharmaceuticalsI can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Oric PharmaceuticalsI Fundamental Analysis

We analyze Oric PharmaceuticalsI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric PharmaceuticalsI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Oric PharmaceuticalsI is currently under evaluation in debt to equity category among related companies. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Oric PharmaceuticalsInc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oric PharmaceuticalsI stock to make a market-neutral strategy. Peer analysis of Oric PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Oric PharmaceuticalsI by comparing valuation metrics with similar companies.

Peers

Oric PharmaceuticalsI Related Equities

MOLNMolecular Partners   16.87   
0%
100.0%
SEERSeerInc   8.38   
0%
49.0%
CGEMCullinan Oncology   6.65   
0%
39.0%
HOWLWerewolf Therapeutics   5.75   
0%
34.0%
PMVPPmv PharmaceuticalsI   4.62   
0%
27.0%
EWTXEdgewise Therapeutics   3.78   
0%
22.0%
PEPGPepGen   2.90   
0%
17.0%
MLYSMineralys Therapeutics   2.60   
0%
15.0%
PHVSPharvaris   2.01   
0%
11.0%
ANEBAnebulo Pharmaceuticals   1.12   
0%
6.0%
CCCCC4 TherapeuticsInc   0.58   
0%
3.0%
ANTXAN2 Therapeutics   0.42   
0%
2.0%
ELVNEnliven Therapeutics   1.42   
8.0%
0%
CELCCelcuity LLC   1.71   
10.0%
0%
IMRXImmuneering Corp   5.23   
31.0%
0%
When determining whether Oric PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticalsinc Stock:

Complementary Tools for Oric Stock analysis

When running Oric PharmaceuticalsI's price analysis, check to measure Oric PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric PharmaceuticalsI is operating at the current time. Most of Oric PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Oric PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Oric PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Oric PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric PharmaceuticalsI. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.96)
Return On Assets
(0.28)
Return On Equity
(0.45)
The market value of Oric PharmaceuticalsInc is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Oric PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Oric PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.